Injectable Weight Management Medications

GLP-1 Medication Comparison
(Injectables)

Medication Type Cost Avg Weight Loss*** How It Works Dosing Common Side Effects
Semaglutide (Wegovy®) GLP-1 agonist $$$ 15% Mimics GLP-1 hormone to reduce appetite and slow digestion Weekly Nausea, diarrhea, constipation
Semaglutide (Ozempic®) GLP-1 agonist $$$ 15% Mimics GLP-1 hormone to regulate blood sugar and reduce appetite Weekly Nausea, vomiting, diarrhea
Liraglutide (Saxenda®) GLP-1 agonist $$$ 10% Activates GLP-1 receptors to increase fullness and reduce hunger Daily Nausea, headache, dizziness
Tirzepatide (Zepbound®) GLP-1/GIP agonist $$ 20% Dual-action: targets both GLP-1 and GIP receptors for enhanced appetite suppression Weekly Nausea, diarrhea, constipation
Tirzepatide (Mounjaro®) GLP-1/GIP agonist $$$ 20% Dual-action: targets both GLP-1 and GIP receptors for blood sugar control and weight loss Weekly Nausea, vomiting, diarrhea
Compounded Semaglutide** GLP-1 agonist $ 15% Same mechanism as branded semaglutide (not FDA-evaluated) Weekly Similar to branded (varies by pharmacy)
Compounded Tirzepatide** GLP-1/GIP agonist $ 20% Same mechanism as branded tirzepatide (not FDA-evaluated) Weekly Similar to branded (varies by pharmacy)

This chart provides general information. Well Brain Body clinicians will help determine which option may be appropriate for your individual needs.

Compounded Medications

These are customized formulations prepared by licensed pharmacies to meet specific patient needs under a provider's supervision. They're created in:

  • 503A Pharmacies: Prepare medications for individual patients

  • 503B Facilities: Produce larger batches of sterile compounds

*Includes membership only. Medication cost extra.                                                                                                                                                                                                                                                                        **Disclaimer: Compounded medications haven't undergone FDA approval. Their safety and effectiveness may differ from commercial drugs. Well Brain Body partners only with accredited U.S. compounding pharmacies meeting rigorous standards.                                                                                                                                                                                                                                                     ***In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone.